Skip to main content

Table 1 Baseline patient demographics and clinical characteristics

From: A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma

Variable Measure Total (N = 12)
Age (years) Mean (SD) 27.3 (2.38)
Median 27.0
Range 23.0–31.0
95% confidence interval (25.7, 28.8)
Gender Female 6 (50.0%)
Male 6 (50.0%)
Race Asian 3 (25.0%)
Caucasian 6 (50.0%)
Other 3 (25.0%)
Height (m) Mean (SD) 1.7 (0.11)
Median 1.7
Range 1.6–1.9
95% confidence interval (1.6, 1.8)
Weight (kg) Mean (SD) 68.5 (17.91)
Median 61.4
Range 46.1–113.3
95% confidence interval (57.1, 79.9)
BMI (kg/m2) Mean (SD) 23.8 (4.47)
Median 23.2
Range 18.6–35.8
  95% confidence interval (20.9, 26.6)
  1. BMI body mass index, SD standard deviation